BioPharmX Corporation (BPMX): Price and Financial Metrics

BioPharmX Corporation (BPMX): $6.12

0.64 (-9.49%)

POWR Rating

Component Grades








Add BPMX to Watchlist
Sign Up

Industry: Miscellaneous




#NR of NR

in industry

BPMX Price/Volume Stats

Current price $6.12 52-week high $6.30
Prev. close $0.56 52-week low $0.25
Day low $5.47 Volume 336,508
Day high $6.30 Avg. volume 2,150,348
50-day MA $0.34 Dividend yield N/A
200-day MA $0.37 Market Cap 111.86M

BPMX Stock Price Chart Interactive Chart >

BPMX Latest News Stream

Event/Time News Detail
Loading, please wait...

BPMX Latest Social Stream

Loading social stream, please wait...

View Full BPMX Social Stream

Latest BPMX News From Around the Web

Below are the latest news stories about BioPharmX Corp that investors may wish to consider to help them evaluate BPMX as an investment opportunity.

BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Timber Pharmaceuticals, it will effect a 1-for-12 reverse stock split of its outstanding common stock. The reverse stock split is expected to be effective for trading purposes as of the commencement of trading on Tuesday, May 19, 2020.

Yahoo | May 15, 2020

The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 13.) …

Benzinga | May 14, 2020

BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting

CAMPBELL, Calif., May 13, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that all proposals related to its proposed merger with Timber Pharmaceuticals LLC ("Timber") were approved by BioPharmX's stockholders at a special meeting held on May…

PR Newswire | May 13, 2020

BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals

CAMPBELL, Calif., May 8, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and related matters as described in the proxy statement/prospectus….

PR Newswire | May 8, 2020

BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement

SAN JOSE, Calif. and WOODCLIFF LAKE, N.J., Jan. 28, 2020 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan…

PR Newswire | January 28, 2020

Read More 'BPMX' Stories Here

BPMX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year -42.93%
2023 N/A
2022 N/A
2021 N/A
2020 0.00%
2019 -84.58%

Continue Researching BPMX

Want to see what other sources are saying about BioPharmX Corp's financials and stock price? Try the links below:

BioPharmX Corp (BPMX) Stock Price | Nasdaq
BioPharmX Corp (BPMX) Stock Quote, History and News - Yahoo Finance
BioPharmX Corp (BPMX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!